Emergent BioSolutions Inc.EBSNYSE
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank29
5Y CAGR-4.0%
Studio
Year-over-Year Change

Price-to-earnings ratio

5Y CAGR
-4.0%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
202512.57+572.9%
2024-2.66-1545.2%
2023-0.16+94.2%
2022-2.80-126.4%
202110.60-31.4%
202015.44-69.7%
201950.98+7.6%
201847.37+101.3%
201723.53-7.7%
201625.48-